<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000423254"><TermName>SJG-136</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called DNA cross-linking agents.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>SJG-136</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Es un tipo de formador de enlaces transversales en el ADN.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-05-23</DateFirstPublished></GlossaryTerm>
